Your browser doesn't support javascript.
loading
Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility.
Xu, Fengzhe; Yu, Evan Yi-Wen; Cai, Xue; Yue, Liang; Jing, Li-Peng; Liang, Xinxiu; Fu, Yuanqing; Miao, Zelei; Yang, Min; Shuai, Menglei; Gou, Wanglong; Xiao, Congmei; Xue, Zhangzhi; Xie, Yuting; Li, Sainan; Lu, Sha; Shi, Meiqi; Wang, Xuhong; Hu, Wensheng; Langenberg, Claudia; Yang, Jian; Chen, Yu-Ming; Guo, Tiannan; Zheng, Ju-Sheng.
Afiliação
  • Xu F; School of Life Sciences, Fudan University, Shanghai, China.
  • Yu EY; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Cai X; Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, 210009, Nanjing, China.
  • Yue L; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Jing LP; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Liang X; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Fu Y; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Miao Z; Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, 510275, Guangzhou, China.
  • Yang M; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, 73000, Lanzhou, China.
  • Shuai M; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Gou W; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Xiao C; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Xue Z; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Xie Y; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Li S; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Lu S; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Shi M; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Wang X; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Hu W; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Langenberg C; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Yang J; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Chen YM; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
  • Guo T; Westlake Intelligent Biomarker Discovery (iMarker) Lab, Westlake Laboratory of Life Sciences and Biomedicine, 310024, Hangzhou, China.
  • Zheng JS; School of Life Sciences, Westlake University, 310024, Hangzhou, China.
Nat Commun ; 14(1): 896, 2023 02 16.
Article em En | MEDLINE | ID: mdl-36797296
ABSTRACT
Identification of protein quantitative trait loci (pQTL) helps understand the underlying mechanisms of diseases and discover promising targets for pharmacological intervention. For most important class of drug targets, genetic evidence needs to be generalizable to diverse populations. Given that the majority of the previous studies were conducted in European ancestry populations, little is known about the protein-associated genetic variants in East Asians. Based on data-independent acquisition mass spectrometry technique, we conduct genome-wide association analyses for 304 unique proteins in 2,958 Han Chinese participants. We identify 195 genetic variant-protein associations. Colocalization and Mendelian randomization analyses highlight 60 gene-protein-phenotype associations, 45 of which (75%) have not been prioritized in Europeans previously. Further cross-ancestry analyses uncover key proteins that contributed to the differences in the obesity-induced diabetes and coronary artery disease susceptibility. These findings provide novel druggable proteins as well as a unique resource for the trans-ancestry evaluation of protein-targeted drug discovery.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Proteoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Proteoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China